SKU: CBL-CJCIPA-21
CJC-1295 with DAC 5mg+ Ipamorelin 5mg Blend 10mg
Out of Stock
For laboratory research use only. Not for human or veterinary use, consumption, or any therapeutic application.
BLEND CJC-1295 with DAC 5mg + Ipamorelin -5mg -10mg is referenced in scientific literature for investigations involving multi-peptide signaling interactions and receptor-associated pathway activity within controlled laboratory settings. Research evaluations commonly assess molecular stability, interaction characteristics, and signaling behavior in preclinical research models.
Analytical Characteristics
• Verified sequence identity
• High-purity lyophilized peptide preparation
• Lot-specific analytical testing performed prior to release
• Molecular mass confirmation via analytical methods
• Independently tested for quality and purity
Structural Classification
BLEND CJC-1295 with DAC 5mg + Ipamorelin -5mg -10mg is categorized as a multi-peptide research formulation engineered for laboratory investigations involving peptide signaling and molecular interaction analysis.
• Lyophilized powder form
• Batch-specific COA available
• Independently tested for quality and purity
• Supplied for laboratory research purposes only
Research Use Only. Not for Human or Veterinary Use.
Composition
Amino Acid Sequence
You May Also Like
Related Products
BPC-157 10mg + TB-500 10mg
BPC-157 10mg + TB-500 10mg
BPC-157 + TB-500 is a dual-peptide research combination consisting of two structurally defined synthetic peptide sequences supplied together in a single vial. This blend is referenced in preclinical research contexts where combined peptide models are investigated under controlled laboratory conditions.
BPC-157 5mg + TB-500 5mg
BPC-157 5mg + TB-500 5mg
BPC-157 + TB-500 is a dual-peptide research combination consisting of two structurally defined synthetic peptide sequences supplied together in a single vial. This blend is referenced in preclinical research contexts where combined peptide models are investigated under controlled laboratory conditions.
Glow Blend 70mg
Glow Blend 70mg
Glow Blend 70 is a multi-peptide research combination consisting of three structurally defined synthetic peptide sequences supplied together in a single vial. This blend is referenced in preclinical research contexts where combined peptide models are investigated under controlled laboratory conditions.
CJC-1295 no DAC+ Ipamorelin Blend 10mg
CJC-1295 no DAC+ Ipamorelin Blend 10mg
CJC-1295 + Ipamorelin Blend is a dual-peptide research combination consisting of two structurally defined synthetic peptide sequences supplied together in a single vial. This blend is referenced in preclinical research contexts where combined peptide models are investigated under controlled laboratory conditions.
BPC-157 10mg + TB-500 10mg
BPC-157 10mg + TB-500 10mg
BPC-157 + TB-500 is a dual-peptide research combination consisting of two structurally defined synthetic peptide sequences supplied together in a single vial. This blend is referenced in preclinical research contexts where combined peptide models are investigated under controlled laboratory conditions.
BPC-157 5mg + TB-500 5mg
BPC-157 5mg + TB-500 5mg
BPC-157 + TB-500 is a dual-peptide research combination consisting of two structurally defined synthetic peptide sequences supplied together in a single vial. This blend is referenced in preclinical research contexts where combined peptide models are investigated under controlled laboratory conditions.
Glow Blend 70mg
Glow Blend 70mg
Glow Blend 70 is a multi-peptide research combination consisting of three structurally defined synthetic peptide sequences supplied together in a single vial. This blend is referenced in preclinical research contexts where combined peptide models are investigated under controlled laboratory conditions.
CJC-1295 no DAC+ Ipamorelin Blend 10mg
CJC-1295 no DAC+ Ipamorelin Blend 10mg
CJC-1295 + Ipamorelin Blend is a dual-peptide research combination consisting of two structurally defined synthetic peptide sequences supplied together in a single vial. This blend is referenced in preclinical research contexts where combined peptide models are investigated under controlled laboratory conditions.